Carboxy Therapy Market - By Device , By Therapy , By Treatment Area , By Application , By End Use Industry , By Geography Analysis - Global Opportunity Analysis & Industry Forecast, 2025-2031.

Carboxy Therapy Market Overview 

The Carboxy Therapy Market is estimated to reach $87.8 million by 2031, growing at a CAGR of 11.2% from 2025 to 2031. Carboxytherapy is a non-surgical dermatological treatment that delivers carbon dioxide gas into the subcutaneous tissue via injections or transdermal application. The Carboxy Therapy Market is primarily driven by growing consumer interest in non-surgical aesthetic therapies, increasing acceptance of carboxy therapy, rising beauty consciousness and incomes, and demand for minimal side effects, and recovery time.

Increasing awareness of Carboxy Therapy and technological developments in Carboxy Therapy are key trends influencing the Carboxy Therapy Market. In January 2025, according to a study by the National Library of Medicine, an increase in public demand led to new safe, and effective approaches for achieving dermal rejuvenation.  One such development in June 2023 was no needle carboxy therapy. According to Alvi Prague, the No-Needle Carboxy Therapy machine T-21 is the latest development of a series of CarboMED devices. This professional tool is designed for transdermal administration of CO2 into the tissues of the face and body without injections and masks.

Carboxy Therapy Market - Report Coverage:

The report: “Carboxy Therapy Market – Forecast (2025-2031)”, by IndustryARC, covers an in-depth analysis of the following segments of the Carboxy Therapy Industry.

Key Takeaways:

North America is the Largest

North America occupies the largest market share in the carboxy therapy market. The region’s advanced healthcare system, high aesthetic spending, and growing demand for minimally invasive procedures drive the rise in carboxy therapy. Especially, in the United States and Canada, interest in anti-aging, cellulite reduction, and skin rejuvenation is increasing. In August 2023, according to the Aesthetic Society’s Aesthetic Plastic Surgery National Databank report, Americans spent $11.8 billion on aesthetic procedures, a 2% rise since 2021. In 2022, procedures grew 14% overall, with nonsurgical treatments up 23%. Women accounted for 95% of procedures, and 48.5% of female university students reported social media is the key influencer for their decisions for aesthetic treatments. 

Tabletop is the Largest Segment

Table Top holds the largest share in the market in 2024. The tabletop model is the preferred choice for clinical professionals due to their efficiency, durability, and advanced functionality than the portable models. Additionally, the precise gas standards, enable the tabletop devices to ensure a more comfortable experience for patients by reducing side effects like discoloring or discomfort compared to less precise portable models. Also, being a tabletop, the machine utilizes very little space compared to the portable models ensuring less maintenance and high performance for the clinical professionals as well as for the wellbeing of the patients. It is also considered to provide high durability, and customizable options for various treatments considering different skin types. 

Injectable is the Largest Segment

Injectable Carboxy Therapy holds the largest share in the market in 2024. This is due to its widespread usage in skin treatments, and cellulite reduction. Additionally, its high efficiency and precise permit of CO2 make it a preferred choice for aesthetic clinics and medical practitioners for an effective, quicker, and long-lasting treatment. According to a 2023 study by the Journal of Cosmetic Dermatology, Carboxy Therapy has successfully been applied for skin aging, cellulite, localized fat deposits, striae distensae, infraorbital hyperpigmentation, scar, lymphedema, androgenetic alopecia, alopecia areata, psoriasis, morphea, and vitiligo. Additionally in March 2024, a study by the National Library of Medicine concluded that over 75% of patients responded with good satisfaction with the Carboxy Therapy which was done on various skin types. 

Growing Demand for Non-Surgical Aesthetic Treatments Drives the Market

There is a huge demand for non-surgical aesthetic treatments due to the rise of patients seeking minimally invasive, effective, and low-risk procedures. Carboxy Therapy gained popularity for skin rejuvenation, cellulite reduction, and dark circle treatment, offering natural collagen stimulation and improved circulation without surgery or downtime due to consumer satisfaction over its minimally invasive non-surgical aesthetic procedure. In 2023, according to the data of ASPS (American Society of Plastic Surgeons) Procedural Statistics, minimally invasive procedures saw a 7 % growth year over year, suggesting that patients are opting for less-invasive options to maintain their beauty regimens economically, even more after the pandemic. Additionally, facial procedures continued to be in high demand, blepharoplasty (eyelid surgery) saw a 5 % increase, possibly reflecting the trend towards less-invasive options, such as procedures performed under local anaesthesia.

For more details on this report - Request for Sample 

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Carboxy Therapy Market. The top 10 companies in this industry are listed below:

1. DTA Medical
2. Cosmo Pro 
3. Carbossiterapia Italiana S.r.l.
4. Mezopharma
5. Beijing Jontelaser Technologies Co., Ltd
6. Alvi Prague
7. Wavemed SRL
8. MEDAiON (Nick Fanavaran Plasma Company) 
9. AAMS BFP Electonique
10. Miranza

Scope of the Report: 

For more Lifesciences and Healthcare Market reports, please click here